All Stories

  1. Authors’ response: Brusini and Papa's comments regarding our review article entitled: “Pigment dispersion syndrome and its implications for glaucoma”
  2. Authors’ response: Lam D, Blah TR, Francis IC. Letter to the Editor regarding the publication: “The clinical and pathogenic spectrum of surgically-induced scleral necrosis”
  3. Higher-order Aberrations and their Visual Impact in Paediatric Blepharokeratoconjunctivitis.
  4. Reproducibility, Repeatability, and Correlation of Central Corneal Thickness Measurement with the Pentacam Scheimpflug System and Ultrasound Pachymetry
  5. Selective laser trabeculoplasty is safe and effective in patients previously treated with prostaglandin analogs: An evidence-based review
  6. Risk factors for secondary Glaucoma in patients with Vogt-Koyanagi-Harada disease
  7. High prevalence of angle-closure glaucoma in Vogt-Koyanagi-Harada disease
  8. Burden and depression among informal caregivers of visually impaired patients in Mexico
  9. Age-related Changes of the Corneal Endothelium in the Hispanic Elderly Population
  10. Rheumatoid arthritis-associated peripheral ulcerative keratitis outcomes after early immunosuppressive therapy
  11. A Practical Approach to Severity Classification and Treatment of Dry Eye Disease: A Proposal from the Mexican Dry Eye Disease Expert Panel
  12. The evolution of the modified osteo-odonto-keratoprosthesis, its reliability, and long-term visual rehabilitation prognosis: An analytical review
  13. Dry eye disease, a prominent manifestation of systemic autoimmune disorders
  14. Update on indications, complications, and outcomes of scleral contact lenses
  15. Current practice in the management of ocular toxoplasmosis
  16. Demographic profile and clinical course of Fuchs endothelial corneal dystrophy in Mexican patients
  17. Infectious Eye Diseases - Recent Advances in Diagnosis and Treatment
  18. Contact Lens-Associated Infectious Keratitis: Update on Diagnosis and Therapy
  19. Polymyositis and dermatomyositis: ocular manifestations and potential sight-threatening complications
  20. Pigment dispersion syndrome and its implications for glaucoma
  21. The clinical and pathogenic spectrum of surgically-induced scleral necrosis: A review
  22. Demographic Profile and Clinical Course of Fuchs Endothelial Corneal Dystrophy in Mexican Patients.
  23. The impact of central foveal thickness and integrity of the outer retinal layers in the visual outcome of uveitic macular edema
  24. Digital Image Processing and Development of Machine Learning Models for the Discrimination of Corneal Pathology: An Experimental Model
  25. Anterior-segment optical coherence tomography for the detection and therapeutic monitoring of corneal disorders
  26. Ramsay Hunt syndrome in a young COVID-19 patient
  27. The molecular basis of neurotrophic keratopathy: Diagnostic and therapeutic implications. A review
  28. In-Vivo AS-OCT Microstructural Analysis of Herpetic Keratitis
  29. Evaluating glaucoma during the times of Covid-19: simple measures may save lives!
  30. Analysis of ocular surface damage and visual impact in patients with primary and secondary Sjögren syndrome
  31. Age-related changes of the corneal endothelium in a Hispanic elderly population.
  32. Multidisciplinary management of neurotrophic and exposure keratopathy.
  33. Introductory Chapter: Current and Future Trends in the Diagnosis and Management of Uveitis
  34. Cogan-Reese Syndrome Multimodal Imaging Analysis: OCT, UBM, and SM.
  35. ​Risk factors for ocular surface damage in dry eye
  36. Intraocular pressure variation during episodes of pigment dispersion and its relationship with the development of pigmentary glaucoma
  37. Somatolactogens and diabetic retinopathy
  38. Cataract Surgery in Patients with Uveitis: Preoperative and Surgical Considerations
  39. Efficacy and safety of pop-titrated versus fixed-energy trans-scleral diode laser cyclophotocoagulation for refractory glaucoma
  40. IL-1α and MMP-9 Tear Levels of Patients with Active Ocular Rosacea before and after Treatment with Systemic Azithromycin or Doxycycline
  41. IL-1α- und MMP-9-Konzentration in der Tränenflüssigkeit von Patienten mit aktiver okulärer Rosazea vor und nach Behandlung mit systemischem Azithromycin oder Doxycyclin
  42. Eficacia del diclofenaco tópico vs. nepafenaco tópico en la reducción del dolor durante la fotocoagulación panretiniana
  43. Variación de la presión intraocular durante episodios de dispersión pigmentaria y su relación con el desarrollo de glaucoma pigmentario
  44. Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis
  45. Effect of Topical Nonsteroidal Anti-inflammatory Drugs on Pupillary Size During Uncomplicated Cataract Surgery
  46. In Response to: “Baddar D, Goldstein DA. HLA-A29-positive Birdshot Chorioretinopathy in a Hispanic Patient”
  47. Blepharokeratoconjunctivitis in childhood: corneal involvement and visual outcome
  48. Síndrome erosivo corneal recurrente enmascarado como queratitis epitelial herpética
  49. Trans-scleral diode laser cyclophotocoagulation for refractory glaucoma after high-risk penetrating keratoplasty
  50. The Importance of an Ophthalmologic Examination in Patients With Juvenile Idiopathic Arthritis
  51. Importancia de la evaluación oftalmológica en pacientes con artritis idiopática juvenil
  52. Blefaroqueratoconjuntivitis estafilocócica en la edad pediátrica
  53. Amantadine Corneal Toxicity:Case Report and Review of the Literature
  54. Importancia del escrutinio para tuberculosis previo a la administración de agentes anti-TNF-α en uveítis: a propósito de un caso clínico
  55. Blepharokeratoconjunctivitis in pediatric patients: risk of corneal involvement and visual outcome
  56. Eficacia del ganciclovir tópico como alternativa terapéutica de la queratitis epitelial herpética
  57. Chapter-73 Serpiginous Choroiditis
  58. Pigment Dispersion Syndrome Masquerading as Acute Anterior Uveitis
  59. Secondary Glaucoma in Patients with Uveitis
  60. Outcomes in anterior uveitis associated with the HLA-B27 haplotype
  61. Recurrent uveitis in a patient with adult onset cyclic neutropenia associated with increased large granular lymphocytes
  62. The Value of Combined Serum Angiotensin-Converting Enzyme and Gallium Scan in Diagnosing Ocular Sarcoidosis
  63. Visual acuity and retinoscopy of preterm and full-term infants during the first year of life
  64. Herpes Zoster Peripheral Ulcerative Keratitis in Patients with the Acquired Immunodeficiency Syndrome
  65. Referral Patterns of Uveitis in a Tertiary Eye Care Center
  66. Systemic Drug Toxicity Trends in immunosuppressive Therapy of Immune and Inflammatory Ocular Disease
  67. Disease Relapse in Patients with Ocular Manifestations of Wegener Granulomatosis
  68. Low-dose Cyclosporin A Therapy in Treating Chronic, Noninfectious Uveitis
  69. Recurrence rate of herpetic uveitis in patients on long-term oral acyclovir
  70. The Value of Combined Serum Angiotensin-converting Enzyme and Gallium Scan in Diagnosing Ocular Sarcoidosis
  71. Systemic Immunosuppressive Therapy and the Occurrence of Malignancy in Patients with Ocular Inflammatory Disease
  72. Resistance to herpes stromal keratitis conferred by an lgG2a-derived peptide
  73. Increasing the Diagnostic Yield of Conjunctival Biopsy in Patients with Suspected Ocular Cicatricia1 Pemphigoid
  74. Disease Relapse in Patients with Ocular Manifestations of Wegener Granulomatosis
  75. Common major histocompatibility complex class II markers in clinical variants of cicatricial pemphigoid.
  76. Posterior Segment Ocular Manifestations in Patients with HLA-B27—associated Uveitis
  77. Low-dose Cyclosporine Therapy in the Treatment of Birdshot Retinochoroidopathy
  78. Atopic keratoconjunctivitis
  79. Transitory cortical blindness post-trauma.
  80. The role of Igh-1 disparate congenic mouse T lymphocytes in the pathogenesis of herpetic stromal keratitis
  81. Cyclic nucleotide mediators in latency and reactivation​ of HSV-1
  82. Ocular Manifestations​ of Systemic Granulomatous Diseases
  83. Ocular Rosacea